Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

biochemistry, genetics and molecular biology

A 24-week, prospective, randomized, open-label, treat-to-target pilot study of obese type 2 diabetes patients with severe insulin resistance to assess the addition of exenatide on the efficacy of U-500 regular insulin plus metformin

Endocrine Practice, Volume 20, No. 11, Year 2014

Objective: To compare the efficacy of 500 U/mL (U-500) regular insulin + metformin with U-500 regular insulin + metformin + exenatide in improving glycemic control in patients with severely insulin-resistant type 2 diabetes mellitus (T2DM).

Distiller, Lawrence A.
1. South Africa, Johannesburg Centre for Diabetes and Endocrinology
Nortje, Hendrik F.M.
1. South Africa, Goodwood-cape Town N1 City Medical Chambers
Wellmann, Holger
1. South Africa, Somerset West Synexus Helderberg Clinical Trial Centre
Amod, Aslam
1. South Africa, Durban The Nelson R. Mandela Medical School
Lombard, Landman
1. South Africa, Sandton Netcare

AFRICAN RESEARCH NEXUS

A 24-week, prospective, randomized, open-label, treat-to-target pilot study of obese type 2 diabetes patients with severe insulin resistance to assess the addition of exenatide on the efficacy of U-500 regular insulin plus metformin

Disclaimer

African Research Nexus

Useful Links

AFRICAN RESEARCH NEXUS

A 24-week, prospective, randomized, open-label, treat-to-target pilot study of obese type 2 diabetes patients with severe insulin resistance to assess the addition of exenatide on the efficacy of U-500 regular insulin plus metformin

Description

Authors & Co-Authors

Disclaimer

African Research Nexus

Useful Links